Hong Guo
- Cancer Research top 5%
- MicroRNA in disease regulation 11
- Cancer-related molecular mechanisms research 7
- Protease and Inhibitor Mechanisms 3
-
- Circular RNAs in diseases 6
- RNA Research and Splicing 4
- RNA Interference and Gene Delivery 3
-
- Inflammatory Bowel Disease 5
-
- Microscopic Colitis 3
- Co-authors
- Yun BaiGang XiongKang YangXingying GuanXueqing XuYun ShiFengjun WangWei Li
- Journals
- Oncogene (1 paper)Biochemical and Biophysical Research Communications (1 paper)The Journal of Infectious Diseases (1 paper)
- Partner nations
- ChinaUnited StatesAustralia
In The Last Decade
Hong Guo
32 papers receiving 794 citations
Peers
Comparison fields: 5 of 77
- Cancer Research 545
- Molecular Biology 529
- Immunology 106
- Hematology 37
- Oncology 66
Countries citing papers authored by Hong Guo
This map shows the geographic impact of Hong Guo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hong Guo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hong Guo more than expected).
Fields of papers citing papers by Hong Guo
This network shows the impact of papers produced by Hong Guo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hong Guo. The network helps show where Hong Guo may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Hong Guo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 0 | |
| 4 | 2024 | 1 | |
| 5 | 2024 | 3 | |
| 6 | 2023 | 2 | |
| 7 | 2020 | 13 | |
| 8 | 2019 | 13 | |
| 9 | 2019 | 13 | |
| 10 | 2019 | 5 | |
| 11 | 2018 | 17 | |
| 12 | 2018 | 24 | |
| 13 | 2018 | 11 | |
| 14 | 2017 | 14 | |
| 15 | 2015 | 11 | |
| 16 | Decreased SFRP2 expression is associated with intermediate and poor karyotypes in de novo acute myeloid leukemia. | 2014 | 5 |
| 17 | 2014 | 41 | |
| 18 | 2010 | 95 | |
| 19 | 2009 | 238 | |
| 20 | 2007 | 6 |
About Hong Guo
Hong Guo is a scholar working on Cancer Research, Hematology and Molecular Biology, having authored 36 papers that have together received 801 indexed citations. Recurring topics across this work include MicroRNA in disease regulation (11 papers), Cancer-related molecular mechanisms research (7 papers), Circular RNAs in diseases (6 papers), Inflammatory Bowel Disease (5 papers), RNA Research and Splicing (4 papers), RNA Interference and Gene Delivery (3 papers), Microscopic Colitis (3 papers) and Protease and Inhibitor Mechanisms (3 papers). The work is most often cited by research in Cancer Research (545 citations), Molecular Biology (529 citations) and Immunology (106 citations). Hong Guo has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Yun Bai, Gang Xiong, Kang Yang, Xingying Guan, Xueqing Xu, Yun Shi, Fengjun Wang, Wei Li, Bin Tang and Wende Tong. Their work appears in journals such as Oncogene, Biochemical and Biophysical Research Communications and The Journal of Infectious Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.